Pediatric Acute and Critical Care COVID-19 Registry of Asia

NCT04395781 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1756

Last updated 2023-03-14

No results posted yet for this study

Summary

In December 2019, an outbreak of pneumonia of unknown aetiology was first reported in the city of Wuhan, Hubei Province, People's Republic of China. Since then, a novel coronavirus, 2019 novel Coronavirus (2019-nCoV) has emerged as the most likely causative agent. To date, it has evolved into a pandemic involving over a million cases and thousands of deaths have been identified, including a high burden in countries like Italy, Spain, United Kingdom and the United States. This study aims to investigate the clinical epidemiology of 2019-novel coronavirus (2019-nCoV) pandemic in Asia.

Conditions

  • COVID
  • Pediatric Disorder

Sponsors & Collaborators

  • King Chulalongkorn Memorial Hospital

    collaborator OTHER
  • Ramathibodi Hospital

    collaborator OTHER
  • Post Graduate Institute of Medical Education and Research, Chandigarh

    collaborator OTHER
  • Rumah Sakit Anak dan Bunda Harapan Kita

    collaborator UNKNOWN
  • National University Hospital, Singapore

    collaborator OTHER
  • St. Marianna University School of Medicine

    collaborator OTHER
  • Tokyo Metropolitan Children's Medical Center, Japan

    collaborator UNKNOWN
  • Aichi Children's Health and Medical Center, Japan

    collaborator UNKNOWN
  • RS H Adam Malik

    collaborator OTHER
  • Children's Hospital of Chongqing Medical University

    collaborator OTHER
  • Zhengzhou Children's Hospital, China

    collaborator OTHER
  • Universiti Kebangsaan Malaysia Medical Centre

    collaborator OTHER
  • Penang Hospital, Malaysia

    collaborator OTHER_GOV
  • Vicente Sotto Memorial Medical Center

    collaborator UNKNOWN
  • Hyogo Prefectural Kobe Children's Hospital

    collaborator OTHER
  • Singapore Clinical Research Institute

    collaborator OTHER
  • KK Women's and Children's Hospital

    lead OTHER_GOV

Principal Investigators

  • Judith Ju Ming Wong · KK Women's and Children's Hospital

Eligibility

Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-18
Primary Completion
2022-12-31
Completion
2023-03-09

Countries

  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Pakistan
  • Singapore

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04395781 on ClinicalTrials.gov